Envista Announces Participation In JP Morgan Healthcare Conference

Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will participate in the JP Morgan Healthcare Conference on January 11, 2021, at 4:30 PM ET. Investors can access the event via Envista's Investor Relations website. Envista is a leading global dental products company, offering a comprehensive portfolio that covers approximately 90% of dentists' clinical needs. Since separating from Danaher Corporation in 2019, Envista has established a strong market position through its commitment to innovation and customer-focused solutions. For more information, visit www.envistaco.com.

Positive

• Participation in the JP Morgan Healthcare Conference may enhance investor engagement.
• Envista's extensive portfolio addresses approximately 90% of dentists' clinical needs, indicating strong market demand.

Negative

• None.

BREA, Calif., Jan. 5, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the JP Morgan Healthcare Conference on Monday, January 11, 2021 at 4:30 PM ET.

Investors will be able to access the event through Envista's Investor Relations website under the subheading Events and Presentations.

ABOUT ENVISTA HOLDINGS CORPORATION

Envista is a global family of more than 30 trusted dental brands, united by a shared purpose: to partner with professionals to improve lives.  Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services.  Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers an estimated 90% of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile.  Envista companies, including KaVo, Kerr, Nobel Biocare, and Ormco, partner with dental professionals to help them deliver the best possible patient care.

Envista separated from Danaher Corporation and became an independent company in 2019. We brought with us the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus to meet the end-to-end needs of dental professionals worldwide.  Envista is now one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.  For more information, please visit www.envistaco.com.

SOURCE Envista Holdings Corporation

FOR FURTHER INFORMATION
John Bedford
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450

View original content to download multimedia:http://www.prnewswire.com/news-releases/envista-announces-participation-in-jp-morgan-healthcare-conference-301201465.html

SOURCE Envista Holdings Corporation

FAQ

What date will Envista participate in the JP Morgan Healthcare Conference?

Envista will participate in the JP Morgan Healthcare Conference on January 11, 2021.

What time is Envista's presentation at the JP Morgan Healthcare Conference?

Envista's presentation is scheduled for 4:30 PM ET.

How can investors access Envista's event?

Investors can access the event through Envista's Investor Relations website under Events and Presentations.

What areas does Envista's portfolio cover?

Envista's portfolio covers approximately 90% of clinical needs for dentists, including dental implants, orthodontics, and digital imaging technologies.

When did Envista become an independent company?

Envista became an independent company in 2019 after separating from Danaher Corporation.